Access to Anti-Diabetic Medicines among Patients Attending Tertiary
Health Facilities in Oyo State, Nigeria

Oladapo Akinyemi, Oluwaseun; Ayeni, Babatunde; Ilesanmi, Olayinka Stephen; Owopetu, Oluwatomi

doi:10.18502/ijdo.v13i4.7995

Volume 13, Issue 4 (12-2021) IJDO 2021, 13(4): 184-193 | Back to browse issues page

‎ 10.18502/ijdo.v13i4.7995

Mendeley

Zotero

RefWorks

Oladapo Akinyemi O, Ayeni B, Ilesanmi O S, Owopetu O. Access to Anti-Diabetic Medicines among Patients Attending Tertiary Health Facilities in Oyo State, Nigeria. IJDO 2021; 13 (4) :184-193
URL: http://ijdo.ssu.ac.ir/article-1-662-en.html

Access to Anti-Diabetic Medicines among Patients Attending Tertiary Health Facilities in Oyo State, Nigeria

Oluwaseun Oladapo Akinyemi

, Babatunde Ayeni

, Olayinka Stephen Ilesanmi ^*

, Oluwatomi Owopetu

Department of Community Medicine, College of Medicine, University of Ibadan, Oyo State, Nigeria Department of Community Medicine, University College Hospital, Ibadan, Oyo State, Nigeria.

Abstract: (1175 Views)

Objective: The management of Diabetes Mellitus (DM) is longterm and can be expensive. This study aimed to describe access to anti-diabetic medicines among patients in tertiary health care facilities in Oyo State, Nigeria. Materials and Methods: This was a hospital-based crosssectional study. The study sites were the University College Hospital (UCH), Ibadan, and Ladoke Akintola University Teaching Hospital, Ogbomosho. It was conducted among 366 diabetic patients who had been attending the endocrinology clinic of these two tertiary health institutions for at least one year. Data analysis was done with the Statistical Program for Social Sciences. Results: Female participants were 186 (50.8%) and 298 (85.6%) depended on close relatives to purchase their drugs. Those who had difficulties affording their anti-diabetic medications were 142 (38.8%) and 80 (56.3%) preferred buying a cheaper brand of antidiabetic medication. Also, 136 (37.2%) respondents had missed their required drugs at some point due to insufficient funds. Males who were able to afford their anti-diabetic medication were 96 (53.3%) compared to 128 (68.8%) females (P-value= 0.002). Those with no formal education had the highest proportion of respondents who could not easily afford anti-diabetic drugs (60.9%), those with tertiary education had the highest proportion of respondents who could afford their medication (77.5%), (P-value=< 0.001). Among those in the 61-70 years age group, 78 (66.1%) achieved glycaemic control compared to 34 (42.5%) of those above 70 years (P-value=< 0.001). Conclusion: To improve affordability, subsidizing the cost of antidiabetic medications and encouraging patients to enrol in the Health Insurance Scheme will be beneficial.

Keywords: Diabetes mellitus, Glycemic control, Anti-diabetic medicines, Nigeria

Full-Text [PDF 177 kb] (410 Downloads)

Type of Study: Research | Subject: Special
Received: 2021/08/5 | Accepted: 2021/10/12 | Published: 2021/11/1

References

1. Asmelash D, Asmelash Y. The burden of undiagnosed diabetes mellitus in adult African population: a systematic review and meta-analysis. Journal of diabetes research. 2019;2019. [DOI:10.1155/2019/4134937]

2. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 8th edition, 2017.

3. Alebiosu OC, Familoni OB, Ogunsemi OO, Raimi TH, Balogun WO, Odusan O, et al. Community based diabetes risk assessment in Ogun state, Nigeria (World Diabetes Foundation project 08-321). Indian journal of endocrinology and metabolism. 2013;17(4):653. [DOI:10.4103/2230-8210.113756]

4. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Health Organization; 2013.

5. World Health Organization, 2008a. The Selection and Use of Essential Medicines. World Health Organization.

6. World Health Organization, 2008b. WHO Collaborating Centre for Drug Statistics Methodology: ATC index with DDDs 2009. Available from: https://www.whocc.no/atc_ddd_index/?code=N05A. Accessed March 3 2021.

7. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes research and clinical practice. 2014;103(2):150-60. [DOI:10.1016/j.diabres.2013.11.001]

8. Dwyer-Lindgren L, Mackenbach JP, Van Lenthe FJ, Flaxman AD, Mokdad AH. Diagnosed and undiagnosed diabetes prevalence by county in the US, 1999-2012. Diabetes care. 2016;39(9):1556-62. [DOI:10.2337/dc16-0678]

9. City Population. Oyo State in Nigeria. Available from: https://www.citypopulation.de/php/nigeria-admin.php?adm1id=NGA031. Accessed March 3 2021.

10. Chinenye S, Young E. State of diabetes care in Nigeria: A review. Nigerian Health Journal. 2011;11(4):101-6.

11. United States Census Bureau. Census and Survey Processing System (CSPro). Available from: https://www.census.gov/data/software/cspro.html. Accessed March 3 2021.

12. SPSS Inc. PASW statistics for windows, version 18.0. Chicago. 2009.

13. Kalyango JN, Owino E, Nambuya AP. Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. African health sciences. 2008;8(2).

14. Enwere OO, Salako BL, Falade CO. Prescription and cost consideration at a diabetic clinic in Ibadan, Nigeria: A report. Annals of Ibadan postgraduate medicine. 2006;4(2). [DOI:10.4314/aipm.v4i2.55232]

15. Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharmacy World & Science. 2008;30(6):876-83. [DOI:10.1007/s11096-008-9243-2]

16. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Archives of internal medicine. 2007;167(17):1853-60. [DOI:10.1001/archinte.167.17.1853]

17. Abioye-Kuteyi EA, Ojofeitimi EO, Fasanu AO, Ijadunola KT. Assessment of dietary knowledge, practices and control in type 2 diabetes in a Nigerian teaching hospital. Nigerian Journal of Medicine. 2005;14(1):58-64. [DOI:10.4314/njm.v14i1.37137]

18. Hawthorne K, Tomlinson S. Pakistani moslems with Type 2 diabetes mellitus: effect of sex, literacy skills, known diabetic complications and place of care on diabetic knowledge, reported self‐monitoring management and glycaemic control. Diabetic Medicine. 1999;16(7):591-7. [DOI:10.1046/j.1464-5491.1999.00102.x]

19. Nsonwu AC, Usoro CA, Etukudo MH, Usoro IN. Glycemic control and serum and urine levels of zinc and magnesium in diabetics in Calabar, Nigeria. Pakistan Journal of Nutrition. 2006;5(1):75-8. [DOI:10.3923/pjn.2006.75.78]

20. Bott U, Jorgens V, Grusser M, Bender R, Muhlhauser I, Berger M. Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabetic medicine. 1994;11(4):362-71. [DOI:10.1111/j.1464-5491.1994.tb00287.x]

21. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clinical therapeutics. 2004;26(4):607-14. [DOI:10.1016/S0149-2918(04)90063-X]

22. Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi medical journal. 2015;27(2):65-70. [DOI:10.4314/mmj.v27i2.7]

23. World Health Organization. Report on the Regional consultation on establishing guidelines for the management and care of acute coronary syndromes, Cairo, Egypt, 27-29 March 2007. 2008.

24. Majeed A, El-Sayed AA, Khoja T, Alshamsan R, Millett C, Rawaf, S. Diabetes Research and Clinical Practice. 2014;103:218-22. [DOI:10.1016/j.diabres.2013.11.008]

25. Whiting DR, Hayes L, Unwin NC. Challenges to health care for diabetes in Africa. European Journal of Preventive Cardiology. 2003;10:103-10. [DOI:10.1177/174182670301000205]